Wedelolactone, a medicinal plant-derived coumestan, induces caspase-dependent apoptosis in prostate cancer cells via downregulation of PKCε without inhibiting Akt

Sarveswaran,Sivalokanathan; Gautam,Subhash  C.; Ghosh,Jagadananda

doi:10.3892/ijo.2012.1664

Wedelolactone, a medicinal plant-derived coumestan, induces caspase-dependent apoptosis in prostate cancer cells via downregulation of PKCε without inhibiting Akt

Authors:
- Sivalokanathan Sarveswaran
- Subhash C. Gautam
- Jagadananda Ghosh
View Affiliations

Affiliations: Vattikuti Urology Institute, Henry Ford Health System, Detroit, MI 48202, USA, Department of Surgery, Henry Ford Health System, Detroit, MI 48202, USA
Published online on: October 16, 2012 https://doi.org/10.3892/ijo.2012.1664
Pages: 2191-2199

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Emerging studies indicate that metabolism of arachidonic acid through the 5-lipoxygenase (5-Lox) pathway plays a critical role in the survival of prostate cancer cells raising the possibility that 5-Lox can be targeted for an effective therapy of prostate cancer. Wedelolactone (WDL), a medicinal plant-derived natural compound, is known to inhibit 5-Lox activity in neutrophils. However, its effect on apoptosis in prostate cancer cells has not been addressed. Thus, we tested the effects of WDL on human prostate cancer cells in vitro. We observed that WDL kills both androgen-sensitive as well as androgen-independent prostate cancer cells in a dose-dependent manner by dramatically inducing apoptosis. We also found that WDL-induced apoptosis in prostate cancer cells is dependent on c-Jun N-terminal Kinase (c-JNK) and caspase-3. Interestingly, WDL triggers apoptosis in prostate cancer cells via downregulation of protein kinase Cε (PKCε), but without inhibition of Akt. WDL does not affect the viability of normal prostate epithelial cells (PrEC) at doses that kill prostate cancer cells, and WDL-induced apoptosis is effectively prevented by 5-oxoETE, a metabolite of 5-Lox (but not by 15-oxoETE, a metabolite of 15-Lox), suggesting that the apoptosis-inducing effect of WDL in prostate cancer cells is mediated via inhibition of 5-Lox activity. These findings indicate that WDL selectivity induces caspase-dependent apoptosis in prostate cancer cells via a novel mechanism involving inhibition of PKCε without affecting Akt and suggest that WDL may emerge as a novel therapeutic agent against clinical prostate cancer in human.

View Figures

View References

1.	T GovindachariK NagarajanB PaiWedelolactone from Eclipta albaJ Sci Indust Res15B6646651956
2.	H WagnerB GeyerY KisoH HikinoGS RaoCoumestans as the main active principles of the liver drugs Eclipta alba and Wedelia calendulaceaPlanta Med52370374198610.1055/s-2007-969188
3.	B SinghAK SaxenaBK ChandanSG AgarwalKK AnandIn vivo hepatoprotective activity of active fraction from ethanolic extract of Eclipta alba leavesIndian J Physiol Pharmacol45435441200111883149
4.	MB PatelVM KadakiaSH MishraSimultaneous estimation of andrographolide and wedelolactone in herbal formulationsIndian J Pharma Sci70689693200810.4103/0250-474X.4542121394279
5.	RK RoyM ThakurVK DixitHair growth promoting activity of Eclipta alba in male albino ratsArch Dermatol Res300357364200810.1007/s00403-008-0860-318478241
6.	WB MorsMC do NascimentoJP ParenteMH da SilvaPA MeloG Suarez-KurtzNeutralization of lethal and myotoxic activities of South American rattlesnake venom by extracts and constituents of the plant Eclipta prostrata (asteraceae)Toxicon2710031009198910.1016/0041-0101(89)90151-72799833
7.	PA MeloMC NascimentoWB MorsG Suarez-KurtzInhibition of the myotoxic and hemorrhagic activities of crotalid venoms by Eclipta prostrata (asteraceae) extracts and constituentsToxicon32595603199410.1016/0041-0101(94)90207-08079371
8.	PA MeloCL OwnbyAbility of wedelolactone, heparin, and para-bromophenacyl bromide to antagonize the myotoxic effects of two crotaline venoms and their PLA2 myotoxinsToxicon37199215199910.1016/S0041-0101(98)00183-49920492
9.	AM SoaresAH JanuarioMV LourencoAM PereiraPS PereiraNeutralizing effects of Brazilian plants against snake venomsDrugs Fut2911051109200410.1358/dof.2004.029.11.851973
10.	M KoboriZ YangD GongV HeissmeyerH ZhuYK JungM AngelicaM GakidisA RaoT SekineF IkegamiC YuanJ YuanWedelolactone suppresses LPS-induced caspase-11 expression by directly inhibiting the IKK complexCell Death Differ11123130200410.1038/sj.cdd.440132514526390
11.	SD SyedM DeepakS YogishaAP ChandrashekarKA MuddarachappaP D’SouzaA AgarwalBV VenkataramanTrypsin inhibitory effect of wedelolactone and demethylwedelolactonePhytother Res17420421200310.1002/ptr.115312722155
12.	BP SagarR PanwarA GoswamiK KadianK TyagiM ChughS DalalR ZafarPharmacokinetic interactions of antihepatotoxic wedelolactone with paracetamol in wistar albino ratsPharmaceutical Biol44554561200610.1080/13880200600885242
13.	LC DiogoRS FernandesS MarcussiDL MenaldoPG RobertoPV MatranguloPS PereiraSC FrancaS GiuliattiAM SoaresMV LourencoInhibition of snake venoms and phospholipases A₂ by extracts from native and genetically modified Eclipta alba: isolation of active coumestansBasic Clin Pharmacol Toxicol104293299200919320636
14.	P PithayanukulB LapettR BavovadaN PakmaneeR SuttisriInhibition of proteolytic and hemorrhagic activities by ethyl acetate extract of Eclipta prostrata against Malayan pit viper venomPharmaceutical Biol45282288200710.1080/13880200701214805
15.	FM LinLR ChenEH LinFC KeHY ChenMJ TsaiPW HsiaoCompounds from Wedelia chinensis synergistically suppress androgen activity and growth in prostate cancer cellsCarcinogenesis2825212529200717942463
16.	N Kaushik-BasuA Bopda-WaffoTT TaleleA BasuPR CostaAJ da SilvaSG SarafianosF NoelIdentification and characterization of coumestans as novel HCV NS5B polymerase inhibitorsNucleic Acids Res3614821496200810.1093/nar/gkm117818203743
17.	H WagnerB FesslerIn vitro 5-lipoxygenase inhibition by Eclipta alba extracts and the coumestan derivative wedelolactonePlanta Med523743771986(In German).
18.	O WerzInhibition of 5-lipoxygenase product synthesis by natural compounds of plant originPlanta Med7313311357200710.1055/s-2007-99024217939102
19.	S GuptaM SrivastavaN AhmadK SakamotoDG BostwickH MukhtarLipoxygenase-5 is overexpressed in prostate adenocarcinomaCancer91737743200110.1002/1097-0142(20010215)91:4%3C737::AID-CNCR1059%3E3.0.CO;2-F11241241
20.	J GhoshCE MyersInhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cellsProc Natl Acad Sci USA951318213187199810.1073/pnas.95.22.13182
21.	J GhoshCE MyersCentral role of arachidonate 5-lipoxygenase in the regulation of cell growth and apoptosis in human prostate cancer cellsAdv Exp Med Biol469577582199910.1007/978-1-4615-4793-8_8410667385
22.	KM AndersonT SeedM VosJ MulshineJ MengW AlrefaiD OuJH Harris5-lipoxygenase inhibitors reduce PC-3 cell proliferation and initiate nonnecrotic cell deathProstate37161173199810.1002/(SICI)1097-0045(19981101)37:3%3C161::AID-PROS5%3E3.0.CO;2-D9792133
23.	RM MorettiMM MontagnaniA SalaM MottaP LimontaActivation of the orphan nuclear receptor RORalpha counteracts the proliferative effect of fatty acids on prostate cancer cells: crucial role of 5-lipoxygenaseInt J Cancer1128793200410.1002/ijc.20387
24.	P YangP CollinT MaddenD ChanB Sweeney-GotschD McConkeyRA NewmanInhibition of proliferation of PC3 cells by the branched-chain fatty acid, 12-methyltetradecanoic acid, is associated with inhibition of 5-lipoxygenaseProstate55281291200310.1002/pros.1024312712407
25.	M MatsuyamaR YoshimuraM MitsuhashiT HaseK TsuchidaY TakemotoY KawahitoH SanoT NakataniExpression of lipoxygenase in human prostate cancer and growth reduction by its inhibitorsInt J Oncol24821827200415010818
26.	J GhoshInhibition of arachidonate 5-lipoxygenase triggers prostate cancer cell death through rapid activation of c-Jun N-terminal kinaseBiochem Biophys Res Commun307342349200310.1016/S0006-291X(03)01201-412859962
27.	SP CreganVL DawsonRS SlackRole of AIF in caspase-dependent and caspase-independent cell deathOncogene2327852796200410.1038/sj.onc.120751715077142
28.	DN DhanasekaranEP ReddyJNK signaling in apoptosisOncogene2762456251200810.1038/onc.2008.30118931691
29.	JM KyriakisP BanerjeeE NikolakakiT DaiEA RubieMF AhmadJ AvruchJR WoodgettThe stress-activated protein kinase subfamily of c-Jun kinasesNature369156160199410.1038/369156a08177321
30.	JM KyriakisJ AvruchSounding the alarm: protein kinase cascades activated by stress and inflammationJ Biol Chem2712431324316199610.1074/jbc.271.40.243138798679
31.	AC MaroneyJP FinnD Bozyczko-CoyneTM O’KaneNT NeffAM TolkovskyDS ParkCY YanCM TroyLA GreeneCEP-1347 (KT 7515), an inhibitor of JNK activation, rescues sympathetic neurons and neuronally differentiated PC12 cells from death evoked by three distinct insultsJ Neurochem73190119121999
32.	S SarveswaranCE MyersJ GhoshMK591, a leukotriene biosynthesis inhibitor, induces apoptosis in prostate cancer cells: synergistic action with LY294002, an inhibitor of phosphatidylinositol 3′-kinaseCancer Lett291167176201019906484
33.	S SarveswaranV ThamilselvanC BrodieJ GhoshInhibition of 5-lipoxygenase triggers apoptosis in prostate cancer cells via down-regulation of protein kinase C-epslilonBiochim Biophys Acta181321082117201110.1016/j.bbamcr.2011.07.01521824498
34.	P BenesL KnopfovaF TrckaA NemajerovaD PinheiroK SoucekM FojtaJ SmardaInhibition of topoisomerase IIα: novel function of wedelolactoneCancer Lett30329382011
35.	JS HoroszewiczSS LeongE KawinskiJP KarrH RosenthalTM ChuEA MirandGP MurphyLNCaP model of human prostatic carcinomaCancer Res43180918181983
36.	ME KaighnKS NarayanY OhnukiJF LechnerLW JonesEstablishment and characterization of a human prostatic carcinoma cell line (PC-3)Invest Urol1716231979447482
37.	KR StoneDD MickeyH WunderliGH MickeyDF PaulsonIsolation of a human prostate carcinoma cell line (DU 145)Int J Cancer21274281197810.1002/ijc.2910210305631930
38.	A van BokhovenM Varella-GarciaC KorchWU JohannesEE SmithHL MillerSK NordeenGJ MillerMS LuciaMolecular characterization of human prostate carcinoma cell linesProstate57205225200314518029
39.	SE LogueM ElgendySJ MartinExpression, purification and use of recombinant annexin V for the detection of apoptotic cellsNat Protoc413831395200910.1038/nprot.2009.14319730422
40.	PJ DuriezGM ShahCleavage of poly(ADP-ribose) polymerase: a sensitive parameter to study cell deathBiochem Cell Biol75337349199710.1139/o97-0439493956
41.	PJ HurdAJ BannisterK HallsMA DawsonM VermeulenJV OlsenH IsmailJ SomersM MannT Owen-HughesI GoutT KouzaridesPhosphorylation of histone H3 Thr-45 is linked to apoptosisJ Biol Chem2841657516583200910.1074/jbc.M109.00542119363025
42.	M RadicT MarionM MonestierNucleosomes are exposed at the cell surface in apoptosisJ Immunol17266926700200410.4049/jimmunol.172.11.669215153485
43.	DS ZieglerAL KungTherapeutic targeting of apoptosis pathways in cancerCurr Opin Oncol2097103200810.1097/CCO.0b013e3282f310f618043263
44.	FH IgneyPH KrammerDeath and anti-death: tumour resistance to apoptosisNat Rev Cancer2277288200210.1038/nrc77612001989
45.	T MashimaT TsuruoDefects of the apoptotic pathway as therapeutic target against cancerDrug Resist Updat8339343200510.1016/j.drup.2005.11.00116338161
46.	H AokiPM KangJ HampeK YoshimuraT NomaM MatsuzakiS IzumoDirect activation of mitochondrial apoptosis machinery by c-Jun N-terminal kinase in adult cardiac myocytesJ Biol Chem2771024410250200210.1074/jbc.M11235520011786558
47.	C HorbinskiCT ChuKinase signaling cascades in the mitochondrion: a matter of life or deathFree Radic Biol Med38211200510.1016/j.freeradbiomed.2004.09.03015589366
48.	SE LogueSJ MartinCaspase activation cascades in apoptosisBiochem Soc Trans3619200810.1042/BST036000118208375
49.	RU JanickeML SprengartMR WatiAG PorterCaspase-3 is required for DNA fragmentation and morphological changes associated with apoptosisJ Biol Chem27393579360199810.1074/jbc.273.16.93579545256
50.	JG WalshSP CullenC SheridanAU LuthiC GernerSJ MartinExecutioner caspase-3 and caspase-7 are functionally distinct proteasesProc Natl Acad Sci USA1051281512819200810.1073/pnas.070771510518723680
51.	S KeithD AbayasiriwardanaD BarboneKU KimC VivoKK LeeTB DansenAE HuntGI EvanVC BroaddusMalignant mesothelioma cells are rapidly sensitized to TRAIL-induced apoptosis by low-dose anisomycin via BimMol Cancer Ther627662776200710.1158/1535-7163.MCT-07-027817938269
52.	A JemalR SiegelE WardY HaoJ XuMJ ThunCancer Statistics, 2009CA Cancer J Clin59225249200910.3322/caac.20006
53.	Z CuligJ HoffmannM ErdelIE EderA HobischA HittmairG BartschG UtermannMR SchneiderK ParczykH KlockerSwitch from antagonist to agonist of the androgen receptor: bicalutamide is associated with prostate tumour progression in a new model systemBr J Cancer81242251199910.1038/sj.bjc.669068410496349
54.	M NamikiS UenoY KitagawaH KonakaA MizokamiE KohTY FukagaiHormonal therapyInt J Clin Oncol12427432200710.1007/s10147-007-0704-8